Thursday, January 17, 2019

Tailoring Treatment to Men or Women with Glioblastoma May Improve Survival

A new study by researchers at the Washington University School of Medicine in St. Louis suggest that tailoring treatments to men and women with glioblastoma, based on the molecular subtypes of their tumors, may help improve survival. The study, supported by National Institutes of Health (NIH),  the Children’s Discovery Institute of Washington University, Joshua’s Great Things, the James S. McDonnell...

Proof-of-Concept Study of Live Tumor Cell Biomarker Test in Prostate Cancer

Results of a risk stratification study designed to demonstrate the ability of a new live tumor cell phenotypic biomarker test to identify patients with low and intermediate grade prostate cancer at risk of aggressive disease, were published in Urology. Prostate cancer is the most common cancer in men in the United States, with an estimated 164,690 news cases diagnosed...

Examining Cost and Benefit: Quality Care in Cancer is Not Only a Matter of Proper Medication

The European Society of Medical Oncology, ESMO, the leading professional organization for medical oncology with over 18,000 members representing oncology professionals from over 150 countries worldwide, this week, shared concerns expressed in a scientific paper discussing the rising costs of cancer medicines. The purpose of the study was to determine if clinical benefits of novel anticancer drugs, measured by the...

Fewer Infections and Less Clotting Associated with Neutral Fluid Displacement Connector

The design of intravenous needleless connectors or NCs plays a substantial role in development of the potentially deadly hospital acquired-catheter related blood stream infection (HA-CRBSI) and the associated risk. Research on different types of needleless IV connectors led a Johns Hopkins cancer center to pilot a new "neutral pressure" IV connector. The results were presented at the at the...

Related articles